| 49183-7 |
Coxiella burnetii phase 2 Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49183-7 |
|
|
|
|
Both |
|
|
|
0 |
C burnet Ph2 IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C burnet; C burnet Ph2; C burnetii; Coxiella burnetii phase II; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Q fev; Q fever; Qfever; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49184-5 |
Coxiella burnetii phase 2 Ab.IgA |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49184-5 |
|
|
|
|
Both |
|
|
|
0 |
C burnet Ph2 IgA Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C burnet; C burnet Ph2; C burnetii; Coxiella burnetii phase II; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; II; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Q fev; Q fever; Qfever; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49185-2 |
Coxiella burnetii phase 1 Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49185-2 |
|
|
|
|
Both |
|
|
|
0 |
C burnet Ph1 IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C burnet; C burnet Ph1; C burnetii; Coxiella burnetii phase I; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; i; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Q fev; Q fever; Qfever; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49186-0 |
Coxiella burnetii phase 1 Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49186-0 |
|
|
|
|
Both |
|
|
|
0 |
C burnet Ph1 IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C burnet; C burnet Ph1; C burnetii; Coxiella burnetii phase I; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Q fev; Q fever; Qfever; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49187-8 |
Coxiella burnetii phase 1 Ab.IgA |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49187-8 |
|
|
|
|
Both |
|
|
|
0 |
C burnet Ph1 IgA Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C burnet; C burnet Ph1; C burnetii; Coxiella burnetii phase I; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; i; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Q fev; Q fever; Qfever; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49188-6 |
Corynebacterium diphtheriae toxin Ab^2nd specimen |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
49188-6 |
|
|
|
|
Both |
|
|
|
0 |
C diphtheriae Tox Ab sp2 Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C diphtheriae; C diphtheriae Tox; Convalescent; Diphtheria; Diptheria; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; Spec; SR |
2.69 |
2.21 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 49189-4 |
Corynebacterium diphtheriae toxin Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
49189-4 |
|
|
|
|
Both |
|
|
|
0 |
C diphtheriae Tox IgG Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C diphtheriae; C diphtheriae Tox; Diphtheria; Diptheria; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
2.21 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 4919-7 |
HLA-Dw9 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-Dw9 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4919-7 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-Dw9 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49190-2 |
Coccidioides sp Ab |
PrThr |
Body fld |
Pt |
Ord |
|
|
ACTIVE |
Coccidioides sp Ab [Presence] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
49190-2 |
|
|
|
|
Both |
|
|
|
0 |
Coccidioides Ab Fld Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Coccidiodes; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; species; spp; Valley fever |
2.56 |
2.21 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49191-0 |
Clostridium tetani toxoid Ab.IgG^1st specimen |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --1st specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
49191-0 |
|
|
|
|
Both |
|
|
|
0 |
C tetani Toxoid IgG sp1 Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C tetani; C tetani Toxoid; c12; c208; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Rc208; Serum; sp1; Spec; SR; Tet; Tetanus; Tetanus toxoid; Ttx |
2.73 |
2.21 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Corrected the word "toxin" in the Component to "toxoid" to more precisely represent what is being measured. |
0 |
| 49192-8 |
Clostridium tetani toxoid Ab.IgG^2nd specimen |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
49192-8 |
|
|
|
|
Both |
|
|
|
0 |
C tetani Toxoid IgG sp2 Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C tetani; C tetani Toxoid; c12; c208; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Rc208; Second; Serum; sp2; Spec; SR; Tet; Tetanus; Tetanus toxoid; Ttx |
2.73 |
2.21 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Corrected the word "toxin" in the Component to "toxoid" to more precisely represent what is being measured. |
0 |
| 49193-6 |
California encephalitis virus Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49193-6 |
|
|
|
|
Both |
|
|
|
0 |
CEV IgM Titr CSF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CA; Calif; Cerebral spinal fluid; Cerebrospinal Fl; CEV; CEV Ab; CEV IgM; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
This term has been undeprecated because upon further review, we confirmed that California encephalitis virus is a distinct member of the CAL serogroup in addition to LaCrosse Virus (LACV), Jamestown Canyon virus (JCV), Snowshoe Hare Virus, and Trivitattus Virus. |
0 |
| 49194-4 |
California encephalitis virus Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49194-4 |
|
|
|
|
Both |
|
|
|
0 |
CEV IgG Titr CSF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CA; Calif; Cerebral spinal fluid; Cerebrospinal Fl; CEV; CEV Ab; CEV IgG; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
This term has been undeprecated because upon further review, we confirmed that California encephalitis virus is a distinct member of the CAL serogroup in addition to LaCrosse Virus (LACV), Jamestown Canyon virus (JCV), Snowshoe Hare Virus, and Trivitattus Virus. |
0 |
| 49195-1 |
California encephalitis virus Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
California encephalitis virus IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
49195-1 |
|
|
|
|
Both |
|
|
|
0 |
CEV IgG Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CA; Calif; CEV; CEV Ab; CEV IgG; Enc; Enceph; Encephalomyelitis; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
2.21 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
This term has been undeprecated because upon further review, we confirmed that California encephalitis virus is a distinct member of the CAL serogroup in addition to LaCrosse Virus (LACV), Jamestown Canyon virus (JCV), Snowshoe Hare Virus, and Trivitattus Virus. |
0 |
| 49196-9 |
Brucella abortus Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Brucella abortus Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
49196-9 |
|
|
|
|
Both |
|
|
|
0 |
B abortus Ab CSF Ql |
|
|
|
N |
|
Abort; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Cerebral spinal fluid; Cerebrospinal Fl; Contagious abortion; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Undulant fever |
2.56 |
2.21 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49197-7 |
Bartonella vinsonii berkhoffii Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49197-7 |
|
|
|
|
Both |
|
|
|
0 |
B vinsonii berkhoffii IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B vinsonii berkhoffii; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49198-5 |
Bartonella vinsonii berkhoffii Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49198-5 |
|
|
|
|
Both |
|
|
|
0 |
B vinsonii berkhoffii IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B vinsonii berkhoffii; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49199-3 |
Bartonella vinsonii berkhoffii Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49199-3 |
|
|
|
|
Both |
|
|
|
0 |
B vinsonii berkhoffii IgG Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B vinsonii berkhoffii; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 492-9 |
Temocillin |
Susc |
Isolate |
Pt |
OrdQn |
MIC |
|
ACTIVE |
Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
492-9 |
|
MIC |
|
|
Observation |
|
|
|
0 |
Temocillin Islt MIC |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Nagaban; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Temopen |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4920-5 |
HLA-DPw1 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-DPw1 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4920-5 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DPw1 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49200-9 |
Bartonella vinsonii berkhoffii Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49200-9 |
|
|
|
|
Both |
|
|
|
0 |
B vinsonii berkhoffii IgM Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B vinsonii berkhoffii; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49201-7 |
Bartonella quintana Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella quintana IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49201-7 |
|
|
|
|
Both |
|
|
|
0 |
B quintana IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B quintana; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cat Scratch Disease; Cat Scratch Fever; CSD; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R quintana; Random; Rochalimae quintana; Rochalimaea quintana; SmQn; Titer; Titered; Titre; Trench fever; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49202-5 |
Bartonella quintana Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella quintana IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49202-5 |
|
|
|
|
Both |
|
|
|
0 |
B quintana IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B quintana; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cat Scratch Disease; Cat Scratch Fever; CSD; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R quintana; Random; Rochalimae quintana; Rochalimaea quintana; SmQn; Titer; Titered; Titre; Trench fever; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49203-3 |
Bartonella henselae Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella henselae IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49203-3 |
|
|
|
|
Both |
|
|
|
0 |
B henselae IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B henselae; B/F; Bacillary angiomaosis; Bacillary pelliosis; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cat Scratch Disease; Cat Scratch Fever; CSD; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R henselae; Random; Rochalimaea henselae; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49204-1 |
Bartonella henselae Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Bartonella henselae IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49204-1 |
|
|
|
|
Both |
|
|
|
0 |
B henselae IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B henselae; B/F; Bacillary angiomaosis; Bacillary pelliosis; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cat Scratch Disease; Cat Scratch Fever; CSD; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R henselae; Random; Rochalimaea henselae; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
